Όλο το DSpace

Πλοήγηση ανά Θέμα "patient risk"

Αποτελέσματα 1-7 από 7

    • Comment on: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis” 

      Tsivgoulis G., Palaiodimou L., Katsanos A.H., Voumvourakis K., Hadjigeorgiou G.M., Heliopoulos I., Karapanayiotides T., Papathanasopoulos P., Kilidireas C., Grigoriadis N. (2019)
      [No abstract available]

    • Exhaled Nitric Oxide (FeNO) in Patients Hospitalized for an Exacerbation of Bronchiectasis and/or COPD: FeNO Levels in COPD and Bronchiectasis 

      Malli F., Gouvani A., Dimeas I., Ladias S., Papathanasiou I.V., Gourgoulianis K.I., Daniil Z. (2021)
      Exhaled nitric oxide (FeNO) represents an important marker of airway inflammation, yet its role in chronic obstructive pulmonary disease (COPD) and/or bronchiectasis is not well studied. We aimed to measure FeNO in patients ...

    • The management of atrial fibrillation in heart failure: an expert panel consensus 

      Farmakis D., Chrysohoou C., Giamouzis G., Giannakoulas G., Hamilos M., Naka K., Tzeis S., Xydonas S., Karavidas A., Parissis J. (2021)
      Heart failure (HF) and atrial fibrillation (AF) often coexist, being closely interrelated as the one increases the prevalence and incidence and worsens the prognosis of the other. Their frequent coexistence raises several ...

    • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 

      Weismüller T.J., Strassburg C.P., Trivedi P.J., Hirschfield G.M., Trivedi P.J., Bergquist A., Said K., Imam M., Lazaridis K.N., Juran B.D., Cheung A., Lindor K.D., Weismüller T.J., Lenzen H., Manns M.P., Ponsioen C.Y., Beuers U., Holm K., Naess S., Karlsen T.H., Schrumpf E., Boberg K.M., Gotthardt D., Rupp C., Färkkilä M.A., Jokelainen K., Marschall H.-U., Benito de Valle M., Thorburn D., Saffioti F., Weersma R.K., Fevery J., Mueller T., Chazouillères O., Schulze K., Schramm C., Almer S., Pereira S.P., Levy C., Mason A., Bowlus C.L., Floreani A., Halilbasic E., Trauner M., Yimam K.K., Milkiewicz P., Milkiewicz P., Huynh D.K., Pares A., Manser C.N., Dalekos G.N., Eksteen B., Invernizzi P., Berg C.P., Kirchner G.I., Sarrazin C., Zimmer V., Fabris L., Braun F., Marzioni M., Schramm C., Chapman R.W., Chapman R.W., Lindor K.D., Imam M., Lindor K.D., Naess S., Karlsen T.H., Schrumpf E., Boberg K.M., Hansen B.E., Hansen B.E., Hansen B.E., on behalf of the, International PSC Study Group (2017)
      Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical ...

    • A revised international prognostic score system for Waldenström’s macroglobulinemia 

      Kastritis E., Morel P., Duhamel A., Gavriatopoulou M., Kyrtsonis M.C., Durot E., Symeonidis A., Laribi K., Hatjiharissi E., Ysebaert L., Vassou A., Giannakoulas N., Merlini G., Repousis P., Varettoni M., Michalis E., Hivert B., Michail M., Katodritou E., Terpos E., Leblond V., Dimopoulos M.A. (2019)
      A staging system was developed a decade ago for patients with Waldenström’s macroglobulinemia (WM), however, since then WM treatments have changed. A revised staging system could better capture prognosis of WM patients in ...

    • Self-reported risk of obstructive sleep apnea syndrome, and awareness about it in the community of 4 insular complexes comprising 41 Greek Islands 

      Adamou A., Giannopoulos A.-S., Arvaniti C., Belios I., Dalampira D., Eleftheriadis G., Zinoviou T., Kassas P., Vavougios G.D., Hatzoglou C., Gourgoulianis K.I., Zarogiannis S.G. (2022)
      Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease that significantly increases morbidity and mortality of the affected population. There is lack of data concerning the OSAS prevalence in the insular part of ...

    • A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms 

      Malde S., Umbach R., Wheeler J.R., Lytvyn L., Cornu J.-N., Gacci M., Gratzke C., Herrmann T.R.W., Mamoulakis C., Rieken M., Speakman M.J., Gravas S., Drake M.J., Guyatt G.H., Tikkinen K.A.O. (2021)
      Context: Understanding men's values and preferences in the context of personal, physical, emotional, relational, and social factors is important in optimising patient counselling, facilitating treatment decision-making, ...